The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Post-progression survival (PPS) according to treatment line, type, and time in phase III trials in advanced colorectal cancer (ACC).
Marc E. Buyse
Employment or Leadership Position - IDDI
Stock Ownership - IDDI
Everardo D. Saad
Employment or Leadership Position - Dendrix Research
Stock Ownership - Dendrix Research
Alastair Matheson
No relevant relationships to disclose